 |
 |
Dear all In Sri Lanka everyone who is admitted to the designated hospitals with PCR+ COVID gets at least Chloroquine /HCQ The Lancet has published a study Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis The findings are : We were unable to confirm a benefit of hydroxychloroquine or chloroquine, when used alone or with a macrolide, on in-hospital outcomes for COVID-19. Each of these drug regimens was associated with decreased in-hospital survival and an increased frequency of ventricular arrhythmias when used for treatment of COVID-19. Has anyone done a critical appraisal of this paper? My question if you are a clinicians would you give HCQ and or macrolide to each and every person (I will add my own criteria after taking an ECG and if there is no abnormal changes of rhythm or other ischaemic changes) Would much value your comments Thank you Kumara *Truth, wisdom, learning, and good sense—these are worth paying for, but too valuable for you to sell.* *Proverbs 23:23* ######################################################################## To unsubscribe from the EVIDENCE-BASED-HEALTH list, click the following link: https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=EVIDENCE-BASED-HEALTH&A=1 This message was issued to members of www.jiscmail.ac.uk/EVIDENCE-BASED-HEALTH, a mailing list hosted by www.jiscmail.ac.uk, terms & conditions are available at https://www.jiscmail.ac.uk/policyandsecurity/